Ashton Thomas Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,359
Closed -$3.09M 467
2026
Q1
$3.09M Buy
+3,359
New +$3.41M 0.39% 60
2025
Q4
Sell
-2,721
Closed -$2.07M 385
2025
Q3
$2.07M Buy
+2,721
New +$2.02M 0.29% 88
2024
Q4
Sell
-3,782
Closed -$3.35M 814
2024
Q3
$3.35M Buy
3,782
+1,103
+41% +$992K 0.65% 33
2024
Q2
$2.5M Buy
+2,679
New +$2.14M 0.6% 43

Other funds holding LLY

Ashton Thomas Securities's LLY Position: Q2 2026 in Review

Ashton Thomas Securities sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,359 shares — an estimated $3.09M sold.

Ashton Thomas Securities first reported a position in LLY in Q2 2024 and held it in 4 quarters. The position peaked at $3.35M in Q3 2024. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ashton Thomas Securities reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Ashton Thomas Securities sold 3,359 Eli Lilly shares in Q2 2026, an estimated $3.09M.
  • Ashton Thomas Securities first reported a position in Eli Lilly in Q2 2024 and held it in 4 quarters.
  • Ashton Thomas Securities's Eli Lilly position peaked at $3.35M in Q3 2024.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.